OSAMA SALEH: Open Payments
NPI 1093785347 · PRINCE FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,844 in 136 payments from 16 companies in 2025. Trend: 2023 $2,147 · 2024 $2,211 · 2025 $1,844
Food & beverage: $1,844
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $312 |
| Indivior Inc. | 22 | $263 |
| Vanda Pharmaceuticals Inc. | 16 | $220 |
| Axsome Therapeutics, Inc. | 12 | $206 |
| Lundbeck LLC | 16 | $196 |
| Collegium Pharmaceutical, Inc. | 11 | $145 |
| Tris Pharma Inc | 15 | $142 |
| E.R. Squibb & Sons, L.L.C. | 4 | $66 |
| Neurocrine BioSciences, Inc. | 4 | $63 |
| Teva Pharmaceuticals USA, Inc. | 3 | $48 |
Products named: CAPLYTA, SUBLOCADE, Jornay PM, Dyanavel XR, Sunosi, ABILIFY ASIMTUFII, HETLIOZ, FANAPT.
Industry payments across MD — which companies pay providers there.
